Ferraro, D. http://orcid.org/0000-0003-4818-3806
Iaffaldano, P.
Guerra, T.
Inglese, M.
Capobianco, M.
Brescia Morra, V.
Zaffaroni, M.
Mirabella, M.
Lus, G.
Patti, F.
Cavalla, P.
Cellerino, M.
Malucchi, S.
Pisano, E.
Vitetta, F.
Paolicelli, D.
Sola, P.
Trojano, M.
Aguglia, U.
Amato, M. P.
Avolio, C.
Balgera, R.
Banfi, P.
Bellantonio, P.
Bergamaschi, R.
Cargnelutti, D.
Cartechini, E.
Chiveri, L.
Clerici, R.
Cocco, E.
Conte, A.
Corea, F.
Danni, M. C.
De Luca, G.
Di Sapio, A.
Ferraro, E.
Galgani, S.
Gallo, A.
Gatto, M.
Gazzola, P.
Granella, F.
Lugaresi, A.
Maimone, D.
Maniscalco, G. T.
Marfia, G. A.
Montepietra, S.
Paolo, C
Pesci, I.
Pozzilli, C.
Carlo, P.
Protti, A.
Quatrale, R.
Realmuto, S.
Romano, S.
Romeo, M.
Salemi, G.
Leonardo, S.
Rocco, T.
Paola, V.
Marika, V.
,
Article History
Received: 16 April 2021
Revised: 28 June 2021
Accepted: 12 July 2021
First Online: 22 July 2021
Declarations
:
: The authors report no conflicts of interest in relation to the contents of this study, but note that patients in the study were treated with a number of disease-modifying drugs and that the authors D.F, P.I, M.I. A.B., V.B.M., M.Z., M.M, G.L., F.P., P.C., M.C., F.V., D.P., P.S., M.T report they have received advisory board membership, speaker honoraria, travel support, research grants, consulting fees or clinical trial support from the manufacturers of these drugs, including Allergan, Almirall, Bayer, Biogen, Bristol Meyers and Squibb, Celgene, CLS Behring, Excemed, FIS, Genzyme, Ipsen, Merck, Novartis, Reload Onlus, Roche, Sanofi, Teva and Ultragenyx.
: Ethical approval was obtained by all participating centers.
: Informed consent was obtained from all individual participants included in the study.